MyDrHank vs Empower Pharmacy

Needle-averse shoppers who want a daily semaglutide tablet, have decided a twelve-month commitment is acceptable, and value a price that never moves as the dose climbs more than a low sticker.

Reasons to consider it

• +The price does not change as your dose is titrated up — its FAQ states it plainly ("The price stays the same at every dose — no surprise price increases"), and dose-indexed pricing is the single most common way a cheap first month becomes an expensive fourth one
• +A genuine oral route on semaglutide: a daily tablet, including one compounded with low-dose ondansetron specifically to blunt the nausea that ends most GLP-1 courses early
• +Every plan length is priced in public — monthly, quarterly, 6-month and yearly, with the total for each term printed beside the per-month figure — before any quiz, intake or email capture

What to weigh up

• −EVERY price the site advertises is a twelve-month prepay rate, and not by accident: the price display always shows the cheapest plan, so "From $X/mo" is always the yearly figure. No page shows a month-to-month rate beside it
• −What the twelve months actually cost, up front: oral semaglutide $2,057 to reach the advertised $171/mo, injectable semaglutide $2,140 to reach $178/mo, and tirzepatide $2,883 to reach $240/mo
• −"Plans start at $171/mo with no contract" is the site's own FAQ wording, and its own price list contradicts it — $171 exists only on the Yearly plan. The genuinely no-contract price is $249

Empower Pharmacy is a compounding pharmacy that fills prescriptions written by clinics and telehealth companies. You can't start GLP-1 treatment with it directly; you need a prescriber first.

Provider background

• +Large, established 503A/503B compounding pharmacy with LegitScript-style certification displayed
• +Serves as the fulfillment backend for many telehealth companies (indirect national reach)

What to weigh up

• −No direct-to-consumer prescribing path -- it does not evaluate or prescribe to new patients itself
• −No public retail pricing anywhere on the site
• −'Who We Serve' explicitly separates Practitioners vs. Patients, confirming a B2B-first model

Regulatory note: the FDA issued a warning letter to Empower Clinic Services, LLC dba Empower Pharmacy in April 2025. We still list and link to Empower Pharmacy; you should know the letter is on the public record before you decide.